Valproic acid inhibits the protective effects of stromal cells against chemotherapy in breast cancer: Insights from proteomics and systems biology
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Valproic acid inhibits the protective effects of stromal cells against chemotherapy in breast cancer: Insights from proteomics and systems biology
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR BIOCHEMISTRY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-06-29
DOI
10.1002/jcb.27196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxidation of SQSTM1/p62 mediates the link between redox state and protein homeostasis
- (2018) Bernadette Carroll et al. Nature Communications
- The Therapeutic Potential of Targeting Tumor Microenvironment in Breast Cancer: Rational Strategies and Recent Progress
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria
- (2017) Allimuthu T. Dharmaraja JOURNAL OF MEDICINAL CHEMISTRY
- DrugBank 5.0: a major update to the DrugBank database for 2018
- (2017) David S Wishart et al. NUCLEIC ACIDS RESEARCH
- Extracellular Acidic pH Activates the Sterol Regulatory Element-Binding Protein 2 to Promote Tumor Progression
- (2017) Ayano Kondo et al. Cell Reports
- Tumor microenvironment and cancer therapy resistance
- (2016) Yu Sun CANCER LETTERS
- A rapid and sensitive method for EphB4 identification as a diagnostic and therapeutic biomarker in invasive breast cancer
- (2016) AliMohammad Sabzghabaee et al. Journal of Cancer Research and Therapeutics
- Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
- (2016) Maxim V. Kuleshov et al. NUCLEIC ACIDS RESEARCH
- Valproic acid induces autophagy by suppressing the Akt/mTOR pathway in human prostate cancer cells
- (2016) Qinghua Xia et al. Oncology Letters
- Cancer: An Oxidative Crosstalk between Solid Tumor Cells and Cancer Associated Fibroblasts
- (2016) Alessandro Arcucci et al. Biomed Research International
- Valproic acid causes radiosensitivity of breast cancer cells via disrupting the DNA repair pathway
- (2016) Yue Luo et al. Toxicology Research
- Proteomics of hot-wet and cold-dry temperaments proposed in Iranian traditional medicine: a Network-based Study
- (2016) Hassan Rezadoost et al. Scientific Reports
- Induction of autophagy by valproic acid enhanced lymphoma cell chemosensitivity through HDAC-independent and IP3-mediated PRKAA activation
- (2015) Meng-Meng Ji et al. Autophagy
- Signaling network of lipids as a comprehensive scaffold for omics data integration in sputum of COPD patients
- (2015) Sadegh Azimzadeh et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation
- (2015) TOSHIKI MAWATARI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1
- (2015) YUN-SUK KWON et al. ONCOLOGY REPORTS
- Microenvironmental regulation of therapeutic response in cancer
- (2015) Florian Klemm et al. TRENDS IN CELL BIOLOGY
- Anti-oxidative stress response genes: bioinformatic analysis of their expression and relevance in multiple cancers
- (2015) Barak Rotblat et al. Oncotarget
- Could valproic acid be an effective anticancer agent? The evidence so far
- (2014) Seth A Brodie et al. Expert Review of Anticancer Therapy
- Proteomics and Traditional Medicine: New Aspect in Explanation of Temperaments
- (2014) Mohieddin Jafari et al. FORSCHENDE KOMPLEMENTARMEDIZIN
- Exploring biological processes involved in embryonic stem cell differentiation by analyzing proteomic data
- (2013) Mohieddin Jafari et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Redox Imbalance and Biochemical Changes in Cancer
- (2013) T. C. Jorgenson et al. CANCER RESEARCH
- EphB4 Tyrosine Kinase Stimulation Inhibits Growth of MDA-MB-231 Breast Cancer Cells in a Dose and Time Dependent Manner
- (2013) Farnaz Barneh et al. DISEASE MARKERS
- New perspectives of valproic acid in clinical practice
- (2013) Lenka Činčárová et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production
- (2012) Zhi Shi et al. BREAST CANCER RESEARCH AND TREATMENT
- The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
- (2012) J M Houthuijzen et al. BRITISH JOURNAL OF CANCER
- Stromal cells in tumor microenvironment and breast cancer
- (2012) Yan Mao et al. CANCER AND METASTASIS REVIEWS
- Implication of Tumor Microenvironment in Chemoresistance: Tumor-Associated Stromal Cells Protect Tumor Cells from Cell Death
- (2012) Magali Castells et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Valproic Acid Increases Formation of Reactive Oxygen Species and Induces Apoptosis in Postimplantation Embryos: A Role for Oxidative Stress in Valproic Acid-Induced Neural Tube Defects
- (2011) E. W. Y. Tung et al. MOLECULAR PHARMACOLOGY
- Autophagy induced by valproic acid is associated with oxidative stress in glioma cell lines
- (2011) J. Fu et al. NEURO-ONCOLOGY
- Crosstalk of reactive oxygen species and NF-κB signaling
- (2010) Michael J Morgan et al. CELL RESEARCH
- Molecular and Therapeutic Potential and Toxicity of Valproic Acid
- (2010) Sébastien Chateauvieux et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
- (2010) Jiahuai Tan et al. Journal of Hematology & Oncology
- Cancer Risk in Long-term Users of Valproate: A Population-Based Case-Control Study
- (2009) J. Hallas et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Valproic acid restores ERα and antiestrogen sensitivity to ERα-negative breast cancer cells
- (2009) N. Fortunati et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer
- (2009) Pierre Farmer et al. NATURE MEDICINE
- Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status
- (2008) Lorena Travaglini et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Breast Tumor Microenvironment: Proteomics Highlights the Treatments Targeting Secretome
- (2008) Shui-Tein Chen et al. JOURNAL OF PROTEOME RESEARCH
- Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells
- (2007) Nicoletta Fortunati et al. CANCER LETTERS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started